4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-000773
Chief Commercial Officer sold 12,956 shares at $4.49 ($58,119)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ludwig Jeffrey Jerome Chief Commercial Officer | 2024-01-03 | Sale 10b5-1 | −12,956 | $4.49 | $58,119 | 99,970 | D |
| Open-market sales · 12,956 sh · avg $4.49 · $58,119 | |||||||
Loading xslF345X05/rdgdoc.xml…